Document And Entity Information |
Jan. 30, 2024 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Document Period End Date | Jan. 30, 2024 |
| Entity Registrant Name | CORBUS PHARMACEUTICALS HOLDINGS, INC. |
| Entity Central Index Key | 0001595097 |
| Entity Emerging Growth Company | false |
| Entity File Number | 001-37348 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 46-4348039 |
| Entity Address, Address Line One | 500 River Ridge Drive |
| Entity Address, City or Town | Norwood |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02062 |
| City Area Code | (617) |
| Local Phone Number | 963-0100 |
| Entity Information, Former Legal or Registered Name | Not Applicable |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.0001 per share |
| Trading Symbol | CRBP |
| Security Exchange Name | NONE |
| Amendment Description | Corbus Pharmaceuticals Holdings, Inc. is filing this Amendment No. 1 to its Current Report on Form 8-K, originally filed with the Securities and Exchange Commission on February 1, 2024 (the "Original 8-K"), solely to re-file the opinion filed as Exhibit 5.1 to the Original 8-K to include the conformed signature, which was inadvertently omitted. The corrected opinion is filed as Exhibit 5.1 hereto and supersedes and replaces in its entirety the opinion filed as Exhibit 5.1 to the Original 8-K. |